SJ000063181

CAS No. 945189-68-4

SJ000063181( —— )

Catalog No. M35449 CAS No. 945189-68-4

SJ000063181 is a potent activator of BMP signaling, exhibiting an EC50 of ≤1 μM. It serves as a valuable chemical probe for BMP signaling analysis, owing to its ability to penetrate zebrafish embryos.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 67 Get Quote
5MG 93 Get Quote
10MG 144 Get Quote
25MG 273 Get Quote
50MG 532 Get Quote
100MG 750 Get Quote
500MG 1521 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    SJ000063181
  • Note
    Research use only, not for human use.
  • Brief Description
    SJ000063181 is a potent activator of BMP signaling, exhibiting an EC50 of ≤1 μM. It serves as a valuable chemical probe for BMP signaling analysis, owing to its ability to penetrate zebrafish embryos.
  • Description
    SJ000063181 is a potent BMP signaling activator with an EC50 ≤1 μM. SJ000063181 can be used as chemical probes to interrogate BMP signaling due to it can penetrate zebrafish embryos.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    TGF-beta/Smad
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    945189-68-4
  • Formula Weight
    296.72
  • Molecular Formula
    C14H14ClFN2O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (337.02 mM; Ultrasonic )
  • SMILES
    CC(C)Cc1cc(no1)C(=O)Nc1ccc(F)c(Cl)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Jamie R Genthe, et al. Ventromorphins: A New Class of Small Molecule Activators of the Canonical BMP Signaling Pathway. ACS Chem Biol.2019 Jul 19;14(7):1673. ?
molnova catalog
related products
  • Pedunculoside

    Pedunculoside is extracted from Ilex rotunda Thunb.

  • Valbenazine

    A novel, highly selective vesicular monoamine transporter 2 (VMAT2) inhibitor; is approved for the treatment of tardive dyskinesia.

  • FTO-IN-3

    FTO-IN-3 is a FTO inhibitor that impair self-renewal in glioblastoma stem cells.